Microfluidics Market to Reach 15.3% CAGR From 2017-2022

June 12, 2018

WELLESLEY, Mass., June 12, 2018 – Expansion in the medical research, chemical and pharmaceutical industries are helping to boost the global market for microfluidics, according to a report by BCC Research.

The global market is expected to see a compound annual growth rate (CAGR) of 15.3% through 2022, indicating a value of $13.9 billion, according to the report Microfluidics: Technologies and Global Markets.

Major players in the market include Abaxis, Abbott Laboratories, Bio-Rad Laboratories, Caliper Life Sciences, Debiotech, Ekigent Technologies, Fluidigm Corp., Gamidor Diagnostics, Hewlett-Packard, ISSYS, Maxwell Sensors, Seiko Epson and Tecan Group.

Research Highlights

• High-throughput screening and compound profiling will increase at a CAGR of 20% from 2017 through 2022. Moreover, this segment accounted for about 45% of the total market and is expected to increase its share to nearly 59% by 2022.
• Caliper Technologies/PerkinsElmer led the industry in terms of issuing patents by producing 207 between 1999 and 2017. The company’s efforts were followed by Sandia at 49, Kodak at 43 and Nanostream at 40.
• The Asia-Pacific region accounts for 34% of the global market for microfluidic technologies, followed by North America (32%), Europe (24%) and the rest of the world (10%).

“Microfluidic devices hold the promise of small analytical laboratories on a chip to identify, separate and purify cells, biomolecules, toxins and other materials with greater speed, sensitivity, efficiency and affordability than standard instruments,” said BCC Research analyst and report author Andrew McWilliams. “Other potential applications of microfluidic devices include detecting chemical and biological warfare agents, delivering precise amounts of prescription drugs, keeping tabs on blood parameters for hospital patients, and monitoring air and water quality.”

Industry Challenges Include Technical Developments

A chief challenge that the microfluidics industry is facing is upstream sample penetration, which currently is a bottleneck to many systems, forcing users to turn to conventional techniques. In response, researchers are working to develop microfluidic sample preparation devices, the best of which are low-cost and easy to use. For example, a team at the University of California at Berkeley is developing a sample prep module which can be used for parallel diagnostics of multiple diseases by taking blood samples from a patient and outputting them as plasma enriched with disease antigens and/or pathogenic nucleic acids for downstream amplification and detection.

Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.

Microfluidics: Technologies and Global Markets( SMC036E )
Publish Date: Jun 2018    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.